Outcome of Atrial Fibrillation in Obesity- Insights from The National Inpatient Sample Database

BackgroundObesity is considered a significant risk factor for numerous cardiovascular conditions. The prevalence of atrial fibrillation (AF) is elevated among patients with obesity. Weight loss has been shown to reverse cardiac remodelling, leading to lower recurrence of AF despite the better prognosis in obese patients. MethodsWe utilized the National Inpatient Sample 2016-2019 to extract patients [&ge;]18 years of age admitted with AF as the primary diagnosis based on ICD 10 codes. We performed univariate and multivariate regression analysis for known coronary risk factors. We divided patients based on their body mass index (BMI), and our primary outcomes were determining the odds of electrical cardioversion (ECV) and cardiac ablation (CA) due to AF. ResultsThe analysis included 1,625,809 weighted patients. Patients include underweight (6.66%), normal BMI (4.03), overweight (6.51%), obesity class I (20.65%), obesity class II (21.45%), and obesity class III (40.7). After multivariate regression analysis, patients with obesity class I, II, or III had higher odds of ECV, irrespectively of coronary risk factors (OR 1.3, 95% CI 1.25-1.37, OR 1.3, 95% CI 1.32-1.43, OR 1.3, 95% CI1.29-1.38, respectively, with statistically significant P values). However, underweight or normal BMI patients had fewer odds of ECV (OR 0.5 95%CI 0.49-0.61 and OR 0.6 95%CI 0.58-0.74, respectively, with P values <0.001). Meanwhile, there was no statistical significance between a BMI and the odds of CA. ConclusionOur study highlights the significant impact of BMI on managing AF, particularly regarding ECV. Patients in higher BMI categories (obesity class I to III) had increased odds of undergoing ECV, suggesting obesity influences treatment approaches and outcomes in AF management. Interestingly, BMI did not affect the likelihood of CA, indicating a complex relationship between body weight and AF treatment modalities warranting further investigation.